Eone-Diagnomics Genome Center is Other Pharmaceuticals and Biotechnology in South Korea that focus on Center Co Ltd business. Founded in 2013. They cover business area such as Eeone Diagnomics Genome Center Co Ltd, medicine, Next generation, technology, edge genomics analysis, various personal genome sequencing and bioinformatic solution, biomedical researcher, physician, individual, personal health, disease.
Other Pharmaceuticals and Biotechnology
2013
( 11 years old in 2024 )
Center Co Ltd
-
4F, 291 Harmony-ro, Yeonsu-Gu
Incheon, 22016
South Korea
Private
Eeone Diagnomics Genome Center Co LtdmedicineNext generationtechnologyedge genomics analysisvarious personal genome sequencing and bioinformatic solutionbiomedical researcherphysicianindividualpersonal healthdisease
* We use standard office opening hours in near Eone-Diagnomics Genome Center's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Eone-Diagnomics Genome Center is Other Pharmaceuticals and Biotechnology business from South Korea that founded in 2013 (11 years old in 2024), Eone-Diagnomics Genome Center business is focusing on Center Co Ltd.
Eone-Diagnomics Genome Center headquarter office and corporate office address is located in 4F, 291 Harmony-ro, Yeonsu-Gu Incheon, 22016 South Korea.
Eone-Diagnomics Genome Center was founded in South Korea.
In 2024, Eone-Diagnomics Genome Center is currently focus on Center Co Ltd sector.
Above is snippet of Google Trends for "Center Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Eone-Diagnomics Genome Center, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
